Abstract

BackgroundThe purpose of the present study was to develop and evaluate a risk score to predict people at high risk of cardiovascular autonomic dysfunction neuropathy (CAN) in Chinese population.Methods and MaterialsA population-based sample of 2,092 individuals aged 30–80 years, without previously diagnosed CAN, was surveyed between 2011 and 2012. All participants underwent short-term HRV test. The risk score was derived from an exploratory set. The risk score was developed by stepwise backward multiple logistic regression. The coefficients from this model were transformed into components of a CAN score. This score was tested in a validation and entire sample.ResultsThe final risk score included age, body mass index, hypertension, resting hear rate, items independently and significantly (P<0.05) associated with the presence of previously undiagnosed CAN. The area under the receiver operating curve was 0.726 (95% CI 0.686–0.766) for exploratory set, 0.784 (95% CI 0.749–0.818) for validation set, and 0.756 (95% CI 0.729–0.782) for entire sample. In validation set, at optimal cutoff score of 5 of 10, the risk score system has the sensitivity, specificity, and percentage that needed subsequent testing were 69, 78, and 30%, respectively.ConclusionWe developed a CAN risk score system based on a set of variables not requiring laboratory tests. The score system is simple fast, inexpensive, noninvasive, and reliable tool that can be applied to early intervention to delay or prevent the disease in China.

Highlights

  • The prevalence of cardiovascular autonomic neuropathy (CAN) is rapidly growing in all populations worldwide, in the developing world

  • The area under the receiver operating curve was 0.726 for exploratory set, 0.784 for validation set, and 0.756 for entire sample

  • We developed a cardiovascular autonomic dysfunction neuropathy (CAN) risk score system based on a set of variables not requiring laboratory tests

Read more

Summary

Introduction

The prevalence of cardiovascular autonomic neuropathy (CAN) is rapidly growing in all populations worldwide, in the developing world. The disease is a major factor in the cardiovascular complications of diabetes mellitus (DM) [1], and affects many other majority segments of general population, such as the elderly, patients with hypertension (HT), metabolic syndrome (MS), and connective tissue disorders [2,3,4,5]. CA function testing using HRV is sensitive, noninvasive, and reproducible; it is applicable for screening a large number of individuals in general population [1,10]. The purpose of the present study was to develop and evaluate a risk score to predict people at high risk of cardiovascular autonomic dysfunction neuropathy (CAN) in Chinese population

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.